Therapy of Head and Neck Squamous Cell Carcinoma with an Oncolytic Adenovirus Expressing HSV-tk
Open Access
- 1 January 2000
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 1 (1), 56-62
- https://doi.org/10.1006/mthe.1999.0014
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapyHuman Gene Therapy, 1998
- Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometryCytometry, 1997
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.Proceedings of the National Academy of Sciences, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences of the United States of America, 1994
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.Molecular and Cellular Biology, 1991
- Interaction of adenoviral E4 and E1b products in late gene expressionVirology, 1990
- Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfectionVirology, 1987
- Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.Molecular and Cellular Biology, 1985